Special Supplement, Fall 2026

Articles

• 

  Fixed-Duration First-Line Therapy for Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) in Canada: A Canadian Expert Clinical Framework

  Versha Banerji, Isabelle Fleury, Alina Gerrie, Christopher Hillis, Robert Puckrin

  2-16

  • PDF (en)